Current management and prognostic factors for adult ependymoma

Michele Reni, Alba A. Brandes

Research output: Contribution to journalArticlepeer-review


The optimum therapeutic management in adult ependymoma remains undefined because of the low Incidence of this disease and because most of reported series mainly refers to childhood, are retrospective, include a small number of patients and span several decades. The purpose of this article is to analyze, discuss and summarize the current available information regarding the therapeutic approach and the prognostic factors and to provide recommendations for ordinary clinical practice. Some important therapeutic issues like the irradiation dose and volume are also analyzed. Finally, the main open questions as well as current and expected investigation trends are discussed.

Original languageEnglish
Pages (from-to)537-545
Number of pages9
JournalExpert Review of Anticancer Therapy
Issue number5
Publication statusPublished - Oct 2002


  • Adult patients
  • Chemotherapy
  • Ependymoma
  • Prognosis
  • Radiotherapy
  • Salvage therapy
  • Surgery

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology


Dive into the research topics of 'Current management and prognostic factors for adult ependymoma'. Together they form a unique fingerprint.

Cite this